{
    "SPADE_N_05429": {
        "Clinical Information": [
            {
                "Medical use": "Hard-to-heal venous leg ulcers",
                "Company": "Inimex Pharmaceuticals",
                "Stage of Development": "Phase I/II",
                "Comments": "No more comments",
                "Clinical Trials": [
                    "ChiCTR2000030939",
                    "ChiCTR2200060982",
                    "ChiCTR2200063622",
                    "ChiCTR2300067840"
                ]
            }
        ],
        "Patent Information": [
            {
                "Patent No": "US 2004/0170642 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2004_0170642_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2004-9-2",
                "Family Info": "CA2418854A1,EP1309345A2,US7658928,US20080166368,WO2002013857A2,WO2002013857A3,WO2002013857A8",
                "Patent Title": "Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof.",
                "Abstract": "Described is a vaccine which comprises at least one antigen and at least one cathelicidin derived antimicrobial peptide or a derivative thereof as well as the use of a cathelicidin derived antimicrobial peptide or a derivative thereof for the preparation of an adjuvant for enhancing the immune response to at least one antigen."
            },
            {
                "Patent No": "WO 2023/075675 A1",
                "Patent Link": "http://www.lens.org/lens/patent/WO_2023_075675_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2023-5-4",
                "Family Info": "SE2151338A1,WO2023/075675A1",
                "Patent Title": "Antibacterial Peptide",
                "Abstract": "The present document is directed to an antimicrobial peptide, pharmaceutical and non- pharmaceutical compositions comprising an amino acid sequence as set forth in SEQ ID NO: 1 or SEQ ID NO: 2 or an amino acid sequence having at least 85% or at least 90%, sequence identity to SEQ ID NO: 1 or SEQ ID NO: 2, and medical and non- medical use the antimicrobial peptide"
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_05429",
            "Peptide Name": "LL-37",
            "Source": "Human lysosomes of polymorphonuclear leukocytes",
            "Family": "Belongs to the cathelicidin family",
            "Gene": "CAMP",
            "Sequence": "LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES",
            "Sequence Length": 37,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P49913",
                "http://www.uniprot.org/uniprot/Q71SN9"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer"
            ],
            "Target Organism": "[Ref.29859288] Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=25 ± 0 μg/ml);ESBL-producing Escherichia coli(MIC=33.3 ± 14.4μg/ml);NDM-1 producing Acinetobacter baumannii(MIC=20.8 ± 7.2 μg/ml);Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=133.3 ± 57.7μg/ml);Fungi:Candida albicans (ATCC 90028)(MIC>400μg/ml)",
            "Hemolytic Activity": "[Ref.29859288] 2.9 ± 0.7% Hemolysis  at 500μg/ml against human red blood cell",
            "Cytotoxicity": "Not included yet",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not included yet",
            "N-terminal Modification": "Not included yet",
            "C-terminal Modification": "Not included yet",
            "Stereochemistry": "Not included yet",
            "Structure Description": "The peptide adopted 1 helices and 30 residues and a curved amphipathic helix-bend-helix motif spanning residues 2-31 followed by a disordered C-terminal tail. The helical bend is located between residues Gly-14 and Glu-16.",
            "Formula": "C205H340N60O53",
            "Mass": 4493.26,
            "PI": 10.61,
            "Net Charge": 6,
            "Hydrophobicity": -0.72,
            "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min",
            "Function": "Antibacterial activity against the Gram-positive and Gram-negative bacteria. Has hemolytic activity.",
            "Literature": [
                {
                    "Title": "Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.",
                    "Pubmed ID": "29859288",
                    "Reference": "Gene. 2018 May 30. pii S0378-1119(18)30617-6.",
                    "Author": "Wanmakok M, Orrapin S, Intorasoot A, Intorasoot S.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=29859288"
                },
                {
                    "Title": "FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis.",
                    "Pubmed ID": "",
                    "Author": "Boman H.G.,Kogner P.,Odeberg J.,Gunne H.,Agerberth B."
                },
                {
                    "Title": "hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules.",
                    "Pubmed ID": "",
                    "Author": "Borregaard N.,Johnsen A.H.,Cowland J.B."
                },
                {
                    "Title": "Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein.",
                    "Pubmed ID": "",
                    "Author": "Zhong J.,Lee J.,Balint R.F.,Hirata M.,Larrick J.W."
                },
                {
                    "Title": "Structural, functional analysis and localization of the human CAP18 gene.",
                    "Pubmed ID": "",
                    "Author": "Francke U.,Li X.,Ma S.,Lee J.,Larrick J.W."
                },
                {
                    "Title": "The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes.",
                    "Pubmed ID": "R1996J1408",
                    "Author": "Olsson B.,Bergman T.,Odeberg J.,Agerberth B.,Gudmundsson G.H."
                },
                {
                    "Title": "Rhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human molecules.",
                    "Pubmed ID": "",
                    "Author": "Welsch U.,Vogelmeier C.,Weiner D.J.,Lang C.,Bals R."
                },
                {
                    "Title": "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).",
                    "Pubmed ID": "R2004J1449",
                    "Author": ""
                },
                {
                    "Title": "Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.",
                    "Pubmed ID": "R2006J1238",
                    "Author": "Wang G.,Miller D.W.,Han H.,Li Y.,Li X."
                },
                {
                    "Title": "Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.",
                    "Pubmed ID": "R2008J1323",
                    "Author": "Wang G."
                }
            ],
            "Frequent Amino Acids": "KRF",
            "Absent Amino Acids": "ACHMOUWY",
            "Basic Residues": 11,
            "Acidic Residues": 5,
            "Hydrophobic Residues": 14,
            "Polar Residues": 18,
            "Positive Residues": 11,
            "Negative Residues": 5,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_03107",
                    "Similarity": 1.0,
                    "Sequence": "ALLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES"
                },
                {
                    "SPADE_ID": "SPADE_N_03128",
                    "Similarity": 1.0,
                    "Sequence": "LLGDFFRKSKEKIGKEFKRIVQR"
                },
                {
                    "SPADE_ID": "SPADE_N_03129",
                    "Similarity": 1.0,
                    "Sequence": "FALLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES"
                }
            ]
        }
    }
}